Creative Medical Technology Holdings (CELZ) Inventory Average (2020 - 2026)
Creative Medical Technology Holdings' (CELZ) quarterly Inventory Average came in at $125000.0 in Q2 2026, up 12475.45% year-over-year from N/an in Q2 2025, and up 12475.45% quarter-over-quarter from $994.0 in Q3 2025.
Analysis
Creative Medical Technology Holdings (CELZ) Inventory Average (2020 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Inventory Average for 6 consecutive years, with $125000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Inventory Average rose 12475.45% year-over-year to $125000.0 in Q2 2026; TTM through Jun 2026 was $125000.0, a 12475.45% increase from a year earlier, with the FY2024 full-year figure at $4394.0, down 47.65% from the prior year.
- Inventory Average was $125000.0 for Q2 2026 at Creative Medical Technology Holdings, up from $994.0 in the prior quarter.
- Over five years, Inventory Average peaked at $125000.0 in Q2 2026 and troughed at $994.0 in Q2 2025.
- A 5-year average of $15258.3 and a median of $8094.0 in 2023 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average plunged 80.1% in 2025 and soared 12475.45% in 2026, its largest moves.
- Over 5 years, Inventory Average stood at $13044.0 in 2022, then sank by 44.85% to $7194.0 in 2023, then tumbled by 61.16% to $2794.0 in 2024, then tumbled by 64.42% to $994.0 in 2025, then soared by 12475.45% to $125000.0 in 2026.
- The last three Inventory Average figures came in at $125000.0 (Q2 2026), $994.0 (Q3 2025), and $994.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 44.10 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 56.98 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 39.30 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 17.49 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 952.69 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 18.37 Mn |
| 10 | Creative Medical Technology Holdings | 1.48 Mn | 1.50 Mn | - | 125,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125,000.00 |
| Sep 30, 2025 | 994.00 |
| Jun 30, 2025 | 994.00 |
| Mar 31, 2025 | 1,594.00 |
| Dec 31, 2024 | 2,794.00 |
| Sep 30, 2024 | 3,394.00 |
| Jun 30, 2024 | 4,994.00 |
| Mar 31, 2024 | 6,594.00 |
| Dec 31, 2023 | 7,194.00 |
| Sep 30, 2023 | 8,994.00 |
| Jun 30, 2023 | 10,194.00 |
| Mar 31, 2023 | 10,194.00 |
| Dec 31, 2022 | 13,044.00 |
| Sep 30, 2022 | 18,259.50 |
| Jun 30, 2022 | 17,387.50 |
| Mar 31, 2022 | 12,508.00 |
| Jun 30, 2020 | 2,000.00 |